StockData
REGENXBIO Inc. logo

REGENXBIO Inc. (RGNX) stock

RGNXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.24−0.08 (-1.09%)

Close on Nov 17, 2026Market cap $477.94MP/E –Yield –

Regenxbio EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Regenxbio's EPS for the twelve months ending Jun 30, 2026 was -$3.79. For fiscal 2025 it was -$3.76. The highest annual figure on record is $2.91 in fiscal 2021.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.76–
FY2024Dec 31, 2024-$4.59–
FY2023Dec 31, 2023-$6.02–
FY2022Dec 31, 2022-$6.50-323.4%
FY2021Dec 31, 2021$2.91–
FY2020Dec 31, 2020-$2.98–
FY2019Dec 31, 2019-$2.58-194.5%
FY2018Dec 31, 2018$2.73–
FY2017Dec 31, 2017-$2.45–
FY2016Dec 31, 2016-$2.38–
FY2015Dec 31, 2015-$2.59–
FY2014Dec 31, 2014-$1.82–
FY2013Dec 31, 2013-$2.50–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0.43–
Q1 FY2026Mar 31, 2026-$1.72-1533.3%
Q4 FY2025Dec 31, 2025-$1.30–
Q3 FY2025Sep 30, 2025-$1.20–
Q2 FY2025Jun 30, 2025-$1.38–
Q1 FY2025Mar 31, 2025$0.12–
Q4 FY2024Dec 31, 2024-$1.01–
Q3 FY2024Sep 30, 2024-$1.17–
Q2 FY2024Jun 30, 2024-$1.05–
Q1 FY2024Mar 31, 2024-$1.38–
Q4 FY2023Dec 31, 2023-$1.43–
Q3 FY2023Sep 30, 2023-$1.41–
Q2 FY2023Jun 30, 2023-$1.66–
Q1 FY2023Mar 31, 2023-$1.53–
Q3 FY2022Sep 30, 2022-$1.75–
Q2 FY2022Jun 30, 2022-$1.58–
Q1 FY2022Mar 31, 2022-$1.79–
Q3 FY2021Sep 30, 2021-$1.37-695.7%
Q2 FY2021Jun 30, 2021-$1.36–
Q1 FY2021Mar 31, 2021-$1.20–
Q4 FY2020Dec 31, 2020-$1.24–
Q3 FY2020Sep 30, 2020$0.23–
Q2 FY2020Jun 30, 2020-$0.91–
Q1 FY2020Mar 31, 2020-$1.08–
Q4 FY2019Dec 31, 2019-$0.72-754.5%
Q3 FY2019Sep 30, 2019-$0.94–
Q2 FY2019Jun 30, 2019-$0.04-113.3%
Q1 FY2019Mar 31, 2019-$0.89-129.3%
Q4 FY2018Dec 31, 2018$0.11–
Q3 FY2018Sep 30, 2018-$0.56–
Q2 FY2018Jun 30, 2018$0.30–
Q1 FY2018Mar 31, 2018$3.04–
Q4 FY2017Dec 31, 2017-$0.51–
Q3 FY2017Sep 30, 2017-$0.67–
Q2 FY2017Jun 30, 2017-$0.47–
Q1 FY2017Mar 31, 2017-$0.82–
Q4 FY2016Dec 31, 2016-$0.74–
Q3 FY2016Sep 30, 2016-$0.69–

More Regenxbio figures

See a number that looks wrong?